Brian Hoffmann | Association for Accessible Medicines
AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

Brian Hoffmann

AAM Board Member
President of US Generics, Hikma Pharmaceuticals
Brian Hoffmann
Brian Hoffmann
Hikma Pharmaceuticals

Brian Hoffmann, President of US Generics, originally joined Hikma Pharmaceuticals USA under its subsidiary, West-Ward Pharmaceuticals. He is responsible for setting the strategic direction of the business and oversees all the commercial, operational and business development functions.

Brian has held positions such as President, Senior Vice President and General Manager, Vice President of Corporate Development and Senior Strategic Projects Director. Prior to 2009, he was a managing consultant at L.E.K Consulting.

Brian holds a Bachelor's Degree in Business Administration from Boston University Questrom School of Management and an MBA from the University of Chicago Booth School of Business.

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.